Neuralace Medical Announces First Patients Enrolled in the AT-PDN Study Evaluating Axon Therapy® for the Treatment of Painful Diabetic Neuropathy
Neuralace Medical intends to utilize the output of the AT-PDN multicenter study to support the FDA 510(k) application for Axon Therapy label expansion to include Treatment for Painful Diabetic Neuropathy
Neuralace Medical Announces Contract Award Totaling $1.4M Over Five Years With The Department of Veterans Affairs, Augusta, Georgia VA for Treatment of Chronic Neuropathic Pain Using Axon Therapy®
The Augusta VA Pain Medicine Service will be offering Axon Therapy to Veterans using Neuralace’s proprietary magnetic peripheral nerve stimulation (mPNS™) technology. Axon Therapy will enable the pain medicine service to combat pain using a non-invasive, painless modality allowing for customized treatment plans